These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27299955)

  • 1. Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia.
    Ardhaoui M; Ennaifer E; Letaief H; Salsabil R; Lassili T; Chahed K; Bougatef S; Bahrini A; El Fehri E; Ouerhani K; Paez Jimenez A; Guizani I; Boubaker MS; Ben Alaya NB
    PLoS One; 2016; 11(6):e0157432. PubMed ID: 27299955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prevalence, Genotype Distribution and Risk Factors of Human Papillomavirus in Tunisia: A National-Based Study.
    Ardhaoui M; Letaief H; Ennaifer E; Bougatef S; Lassili T; Bel Haj Rhouma R; Fehri E; Ouerhani K; Guizani I; Mchela M; Chahed K; Chahed MK; Boubaker MS; Bouafif Ben Alaya N
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-vaccination prevalence and genotype distribution of human papillomavirus infection among women from urban Tunis: a cross-sectional study.
    Guettiti H; Ennaifer E; Attia L; Chelly D; Alaya NB; Aissa RB; Laassili T; Boubaker S
    Asian Pac J Cancer Prev; 2014; 15(21):9361-5. PubMed ID: 25422225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
    Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
    Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
    Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
    Tay SK; Oon LL
    Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.
    Senapati R; Nayak B; Kar SK; Dwibedi B
    BMC Infect Dis; 2017 Jan; 17(1):30. PubMed ID: 28056826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.
    Chen X; Wallin KL; Duan M; Gharizadeh B; Zheng B; Qu P
    J Med Virol; 2015 Nov; 87(11):1966-72. PubMed ID: 26073652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
    BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
    Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
    J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.
    Borena W; Grünberger M; Widschwendter A; Kraxner KH; Marth E; Mayr P; Meier J; Ruth N; Guerrero AT; Marth C; Holm-von Laer D
    BMC Public Health; 2016 Aug; 16(1):889. PubMed ID: 27565569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
    Krings A; Dunyo P; Pesic A; Tetteh S; Hansen B; Gedzah I; Wormenor CM; Amuah JE; Behnke AL; Höfler D; Pawlita M; Kaufmann AM
    PLoS One; 2019; 14(6):e0218762. PubMed ID: 31246997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China.
    Bi Q; Zhang L; Zhao Z; Mu X; Zhang M; Wang P
    J Med Virol; 2015 Dec; 87(12):2114-21. PubMed ID: 26069229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population.
    Xu HH; Lin A; Chen YH; Dong SS; Shi WW; Yu JZ; Yan WH
    BMJ Open; 2017 Jun; 7(6):e014135. PubMed ID: 28601819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection in females with normal cervical cytology: Genotyping and phylogenetic analysis among women in Punjab, Pakistan.
    Aziz H; Iqbal H; Mahmood H; Fatima S; Faheem M; Sattar AA; Tabassum S; Napper S; Batool S; Rasheed N
    Int J Infect Dis; 2018 Jan; 66():83-89. PubMed ID: 29138009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.
    Couture MC; Page K; Stein ES; Sansothy N; Sichan K; Kaldor J; Evans JL; Maher L; Palefsky J
    BMC Infect Dis; 2012 Jul; 12():166. PubMed ID: 22839728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human papillomavirus infection in women in the Autonomous Region of Inner Mongolia: A population-based study of a Chinese ethnic minority.
    Wang X; Ji Y; Li J; Dong H; Zhu B; Zhou Y; Wang J; Zhou X; Wang Y; Peppelenbosch MP; Pan Q; Ji X; Liu D
    J Med Virol; 2018 Jan; 90(1):148-156. PubMed ID: 28661048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.